Zhitong Finance App News, Wangshan Wangshui-B (02630.HK) issued an announcement. Recently, the Group's self-developed new drug simenafil hydrochloride tablets (trade name: Onvidia®, R&D code: TPN171) for treating erectile dysfunction (ED) indications have been officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Drug Administration on September 30, 2026.

Zhitong Finance App News, Wangshan Wangshui-B (02630.HK) issued an announcement. Recently, the Group's self-developed new drug simenafil hydrochloride tablets (trade name: Onvidia®, R&D code: TPN171) for treating erectile dysfunction (ED) indications have been officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Drug Administration on September 30, 2026.